Citius Pharmaceuticals, Inc. (CTXR) Earnings
|
Expand Research on CTXR
| Next EPS Date | 12/17/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -313.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
12/17/26  |
Q426 | N/A | -$0.25 | N/A | N/A | $9.77M | N/A | N/A | N/A | ||
| 8/17/26 | Q326 | -$0.34 | $0.03 | -$0.37 | $1.5M | $12.52M | N/A |  | | Details | |
| 8/12/25 |
Q325 | N/A | $0.05 | N/A | N/A | $16.06M | N/A | N/A | N/A | ||
| 5/14/25 | Q225 | -$0.11 | $0.00 | -$0.11 | N/A | N/A | N/A | | | Details | |
| 2/7/25 |
Q125 | N/A | $0.04 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/27/24 |
Q424 | N/A | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/13/24 | Q324 | -$0.06 | -$0.05 | -$0.01 | N/A | N/A | N/A | | | Details | |
| 8/8/24 | Q324 | N/A | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A |
